Published in J Exp Clin Cancer Res on June 01, 2004
Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants. PLoS One (2014) 1.37
Early effect of hepatic artery TNF-alpha infusion on systemic hemodynamics and inflammation: a dose-response study in pigs. Int J Colorectal Dis (2009) 0.78
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Decompressive craniectomy may cause diagnostic challenges to assess brain death by computed tomography angiography. Minerva Anestesiol (2013) 2.02
Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain. Anesth Analg (2003) 1.43
Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines. J Immunother (2001) 1.42
Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res (1997) 1.42
Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo. Cell Death Dis (2011) 1.22
New agents for sedation in the intensive care unit. Crit Care Clin (2001) 1.17
Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev (1998) 1.16
Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage (2000) 1.12
Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem (2003) 1.08
Bullous pemphigoid: an unusual and insidious presentation of breast cancer. Clin Oncol (R Coll Radiol) (2003) 1.05
CA 72-4 serum marker--a new tool in the management of carcinoma patients. Cancer Invest (1995) 1.05
Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg (2000) 1.02
Squamous and adenosquamous cell carcinomas of the gallbladder. J Exp Clin Cancer Res (2005) 0.99
Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol (2010) 0.99
P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology (2002) 0.99
Toxic shock syndrome due to group C streptococci. A case report. Intensive Care Med (1996) 0.98
Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer (1989) 0.96
Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation--role of arachidonic acid metabolism. Thromb Haemost (2000) 0.95
S-100 and NSE as serum markers in melanoma. Acta Oncol (1997) 0.94
Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockade. J Neurochem (2008) 0.94
Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol (2000) 0.92
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. J Cancer Res Clin Oncol (2000) 0.91
Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neuroscience (2001) 0.90
Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer (1995) 0.90
Integrin Beta-4 expression in colorectal-cancer. Int J Oncol (1994) 0.90
Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodies. Clin Chem (1989) 0.90
Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study. J Am Coll Surg (2000) 0.90
Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol (2001) 0.89
Aortic coarctation in the elderly: how many errors lie behind an unexpected diagnosis? Intern Emerg Med (2007) 0.89
Ia-like antigens on freshly explanted human melanoma. Clin Immunol Immunopathol (1981) 0.89
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. Int J Cancer (1997) 0.89
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study. Clin Cancer Res (2001) 0.87
Unusual presentation of leptospirosis in the late stage of pregnancy. Minerva Anestesiol (2007) 0.87
Class I major histocompatibility complex enhancement by recombinant leukocyte interferon in the peripheral blood mononuclear cells and plasma of melanoma patients. Cancer Res (1991) 0.86
Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant (2008) 0.86
Selective location of palisaded myofibroblastoma with amianthoid fibres. J Clin Pathol (1991) 0.85
Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion. Cancer (1999) 0.84
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients. Anticancer Res (1996) 0.83
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study. J Immunother (1999) 0.83
Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. A preliminary finding. Dis Colon Rectum (1989) 0.83
Effect of somatostatin in controlling bleeding from esophageal varices. Ital J Surg Sci (1987) 0.83
Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells. Cell Mol Life Sci (2004) 0.82
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma. J Exp Clin Cancer Res (2003) 0.82
The combined use of VIGI@ct (bioMérieux) and fluorescent amplified length fragment polymorphisms in the investigation of potential outbreaks. J Hosp Infect (2007) 0.82
Nipple sparing mastectomy with immediate breast reconstruction: a short term analysis of our experience. J Exp Clin Cancer Res (2006) 0.82
Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology (2000) 0.82
Influence of ventilator settings on patient-ventilator synchrony during pressure support ventilation with different interfaces. Intensive Care Med (2010) 0.82
TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer (1993) 0.82
[Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer]. Clin Ter (2009) 0.81
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma. J Exp Clin Cancer Res (2003) 0.81
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei. J Exp Clin Cancer Res (2003) 0.81
Flow cytometric study of lymphocyte subsets in patients at different stages of colorectal carcinoma. Dis Colon Rectum (1994) 0.81
Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Cancer Res (1996) 0.81
Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei. Neuroscience (2002) 0.81
Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon. Int J Cancer (1990) 0.81
Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Oncol (2000) 0.81
Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment. J Intern Med (2012) 0.81
[Laparoscopic intraperitoneal antiblastic hyperthermic chemoperfusion in the treatment of refractory neoplastic ascites. Preliminary results]. Suppl Tumori (2006) 0.81
The application of hyperthermia in regional chemotherapy. Semin Surg Oncol (1998) 0.80
120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study. In Vivo (2007) 0.80
Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices. Support Care Cancer (2004) 0.80
Acute severe arterial hypertension: therapeutic options. Curr Drug Targets (2009) 0.79
Second-line gemcitabine in refractory stage IV non small-cell lung cancer: a phase II trial. Clin Lung Cancer (2000) 0.79
Mu3 opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release. Cancer Lett (1999) 0.79
Hypoalbuminaemia and propofol pharmacokinetics. Br J Anaesth (2005) 0.79
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. Transplant Proc (2009) 0.79
Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status. J Exp Clin Cancer Res (2007) 0.78
[Serum levels of tobramycin during selective decontamination of the gastrointestinal tract]. Minerva Anestesiol (1988) 0.78
Melan-A/MART-1 antigen expression in cutaneous and ocular melanomas. J Immunother (1997) 0.78
The integrated treatment of peritoneal carcinomatosis. A preliminary experience. J Exp Clin Cancer Res (1999) 0.78
Nasal obstruction improvement induced by topical furosemide in subjects affected by perennial nonallergic rhinitis. Am J Rhinol (1998) 0.77
Immunocytochemical diagnosis of amelanotic metastatic melanoma using monoclonal antibodies HMB-45 and Ep1-3. Melanoma Res (1994) 0.77
The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities. World J Surg (1988) 0.77
[Clinical guidelines for the management of gastrointestinal stromal tumors]. Clin Ter (2006) 0.77